Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Immunol Rev. 2017 Jan;275(1):296–312. doi: 10.1111/imr.12511

Figure 3. Neutralization sensitivity of SHIVs to anti-HIV-1 bnMAbs.

Figure 3

The IC50 titers of the bnMAbs shown were determined against a panel of replication competent SHIVs in a single-round of infection assay with TZM-bl target cells. The SHIV stocks were made in rhesus PBMCs. The clade of each SHIV is indicated in parenthesis.